GoldenTree Asset Management LP
+3.45%
3M Return
$10.960
-0.030 (-0.27%)收盤時
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
Currently, Ardent Health Partners Inc is trading at $10.96, which is below the average analyst price target of $13.67. The forward P/E ratio is 10.70, indicating a potentially attractive valuation. However, the recent earnings report showed a GAAP EPS of $0.12, missing expectations by $0.05, which raises concerns about profitability. The RSI is at 46.56, suggesting the stock is nearing oversold territory, but is not yet a strong buy signal. The main risk is the 1-year change of -13.50%, indicating significant volatility and potential for further declines.

Ardent Health Partners Q2 Earnings Analysis

Ardent Health Director Increases Stock Holdings

Ardent Health Director Increases Stock Holdings

Ardent Health Appoints New CEO Amid Financial Guidance Reaffirmation

Ardent Health Appoints New CEO to Drive Growth
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings. It operates in the Healthcare sector.
Currently, Ardent Health Partners Inc is trading at $10.96, which is below the average analyst price target of $13.67. The forward P/E ratio is 10.70, indicating a potentially attractive valuation. However, the recent earnings report showed a GAAP EPS of $0.12, missing expectations by $0.05, which raises concerns about profitability. The RSI is at 46.56, suggesting the stock is nearing oversold territory, but is not yet a strong buy signal. The main risk is the 1-year change of -13.50%, indicating significant volatility and potential for further declines.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。